Thrombolex, Inc.
Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters used in interventional procedures, particularly in catheter-directed thrombolysis (CDT) of thrombus in patients affected by A+VTE conditions. A recent comprehensive scientific review revealed that 10 million cases of venous thromboembolism (VTE) occur annually on a worldwide basis with significant mortality and morbidity.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2016
About Us
To create innovative endovascular catheters for use in the treatment of patients with arterial and venous thromboembolic (A+VTE) conditions.
Our Vision
Orchestrate the medical profession’s identified unmet needs with our unique product development capabilities.
Our Goal
To create a continuous stream of new products based on the original BASHIR™ platform technology, which will improve the treatment outcomes for patients suffering from A+VTE conditions.